WANBURY
Back to Income Statement
|
WANBURY Last 5 Year Earnings Per Share (EPS) History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Adjusted EPS | ₹9.32 | ₹17.09 | ₹-3.18 | ₹24.94 | ₹-5.04 |
What is the latest Earnings Per Share (EPS) of WANBURY ?
| Year | Earnings Per Share (EPS) |
|---|---|
| Mar2025 | ₹9.32 |
| Mar2024 | ₹17.09 |
| Mar2023 | ₹-3.18 |
| Mar2022 | ₹24.94 |
| Mar2021 | ₹-5.04 |
How is Earnings Per Share (EPS) of WANBURY Trending?
| Years | Earnings Per Share (EPS) | % Change | |
|---|---|---|---|
| Mar2025 | ₹9.32 | -45.47 | |
| Mar2024 | ₹17.09 | Positive | |
| Mar2023 | ₹-3.18 | Negative | |
| Mar2022 | ₹24.94 | Positive | |
| Mar2021 | ₹-5.04 | - | |
Compare Earnings Per Share (EPS) of peers of WANBURY
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| WANBURY | ₹928.9 Cr | -2% | 27.7% | 29.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹417,028.0 Cr | 0.3% | 9% | 8.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹170,237.0 Cr | 1.9% | 5.9% | 12.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹146,801.0 Cr | 0.6% | 9.5% | 45% | Stock Analytics | |
| CIPLA | ₹108,861.0 Cr | 1.6% | 1.8% | -7.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,435.0 Cr | -1.5% | 5.7% | 14.5% | Stock Analytics | |
WANBURY Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| WANBURY | -2% |
27.7% |
29.3% |
| SENSEX | -1.8% |
-1.6% |
7.3% |
You may also like the below Video Courses